Anti-GFAP staining exhibited that the astrocytes in the demyelinating areas were in metabolic disorder and had several anti-GFAP strong positive substances (weak positive reaction in control dogs) in their cytoplasm (Fig. 1C). The gene discussed is GFAP; the disease is metabolic disease.